S7A
| Resources - ICH Guidances |
S7A: Safety Pharmacology Studies for Human Pharmaceuticals:
The ICH guideline reached Step 4 of the ICH process in November 2000. This document addresses the definition, objectives and scope of safety pharmacology studies. It also addresses which studies are needed before initiation of Phase 1 clinical studies as well as information needed for marketing.
ICHS7A.pdf
| < Prev | Next > |
|---|
Most Recent Guidances (All Agencies)
- Factors Influencing the Classification of Products at the Device-Drug Interface
- FDA proposes draft guidelines intended to improve the representation of women in medical device clinical studies
- S2 R1
- Good Laboratory Practice for Nonclinical Laboratory Studies
- Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination
